Our Program

exogen™ Pro Line is an exclusive brand proudly produced by C3 Global Biosciences, Inc. Our line was developed to support physicians and other professionals who have their patients best interest at heart and are committed to better health and wellness. These products can’t be found anywhere else as each formulation uses carefully selected ingredients and is always manufactured at therapeutic levels and potencies. At c3GBS we are here to serve and support healthcare providers and professionals with the safest and highest quality Cannabidiol (CBD) products. This program not only will benefit your clients, you will have the ability to grow and expand your business.

Why Choose C3 Global Biosciences?

Industry Leaders In A League of Our Own

We Are Changing The Paradigm

Many health care professionals are no longer content to prescribe drugs that merely manage symptoms.

An Exclusive Line for Healthcare Professionals

exogen™ is exclusive to you.  It can’t be found on Amazon, Ebay or any other e-commerce site.

Setting The Standard For Quality & Safety

We care about the health and well-being of your patients, clients & customers.

Growing, Expanding & Building Your Business

Placing the patient at the center of the healthcare continuum and providing alternative health.

Service & Support From Industry Professionals

Our team has decades of both passion & experiences serving the healthcare industry.

The Natural Power of Adaptogens

We are constantly innovating with the goal of producing the most innovative products available.


How Is The Endocannabinoid System Involved In Epilepsy?

There are defects in the endocannabinoid system in persons with epilepsy.

In one study, 12 patients with newly diagnosed temporal lobe epilepsy had lower levels (p < .01) of anandamide in CSF as compared to controls. In tissue removed from 30 patients undergoing epilepsy surgery, the levels of CB1 receptor messenger RNA were lower in some excitatory nerve endings as compared to the specimens obtained postmortem from persons without epilepsy.

It was also noted that in the epilepsy patients, there was a reduced expression of diacylglycerol lipase α, the enzyme that synthesizes 2-AG in postsynaptic neurons. (Recall that 2-AG is a fully efficacious agonist of both CB1 and CB2 receptors.)

Health & Wellness Defined

The Nexus Between Science & Nature

Our Products

Discover The Difference